- Home
- SKYE vs HFFG Comparison
SKYE vs HFFG Comparison
Compare SKYE & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- HFFG
- Stock Information
- Founded
- SKYE 2012
- HFFG N/A
- Country
- SKYE United States
- HFFG United States
- Employees
- SKYE N/A
- HFFG N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- HFFG Food Distributors
- Sector
- SKYE Health Care
- HFFG Consumer Discretionary
- Exchange
- SKYE Nasdaq
- HFFG Nasdaq
- Market Cap
- SKYE 94.0M
- HFFG 168.8M
- IPO Year
- SKYE N/A
- HFFG N/A
- Fundamental
- Price
- SKYE $2.73
- HFFG $2.95
- Analyst Decision
- SKYE Buy
- HFFG
- Analyst Count
- SKYE 6
- HFFG 0
- Target Price
- SKYE $18.67
- HFFG N/A
- AVG Volume (30 Days)
- SKYE 167.7K
- HFFG 46.2K
- Earning Date
- SKYE 02-09-2025
- HFFG 11-12-2024
- Dividend Yield
- SKYE N/A
- HFFG N/A
- EPS Growth
- SKYE N/A
- HFFG N/A
- EPS
- SKYE N/A
- HFFG N/A
- Revenue
- SKYE N/A
- HFFG $1,177,258,000.00
- Revenue This Year
- SKYE N/A
- HFFG $5.18
- Revenue Next Year
- SKYE N/A
- HFFG $2.73
- P/E Ratio
- SKYE N/A
- HFFG N/A
- Revenue Growth
- SKYE N/A
- HFFG 1.53
- 52 Week Low
- SKYE $2.25
- HFFG $2.46
- 52 Week High
- SKYE $19.41
- HFFG $5.91
- Technical
- Relative Strength Index (RSI)
- SKYE 37.40
- HFFG 29.57
- Support Level
- SKYE $2.31
- HFFG $2.93
- Resistance Level
- SKYE $3.04
- HFFG $3.30
- Average True Range (ATR)
- SKYE 0.30
- HFFG 0.11
- MACD
- SKYE 0.07
- HFFG -0.04
- Stochastic Oscillator
- SKYE 44.68
- HFFG 10.71
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The Company's business consists of one operating segment; HF Group, which operates solely in the United States. The Company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.